NPS/Enzon Merger Provides Additional Leverage In Search For Preos Partner

The NPS/Enzon $1.6 bil. merger deal provides more leverage to the companies' search for a partner for the osteoporosis treatment Preos

More from Archive

More from Pink Sheet